Cantor Fitzgerald, a leading financial services firm, today announced that Cantor Fitzgerald, together with its affiliate BGC Partners, Inc., raised approximately $12 million for dozens of charities around the world, at the companies’ annual Charity Day on September 11, 2015. Each year, Cantor Fitzgerald and BGC Partners donate 100% of the global revenues generated on Charity Day to the Cantor Fitzgerald Relief Fund, and to date has raised approximately $125 million globally since its inception.
“We will never forget all of our friends and colleagues who perished on 9/11. Charity Day represents our company’s fundamental commitment to helping others, and allows us to commemorate the events of that day. Giving back is our way of remembering those who lost their lives on 9/11, turning a day of tragedy into a positive and uplifting day for our employees and friends,” said Howard W. Lutnick, Chairman and Chief Executive Officer of Cantor Fitzgerald, L.P. and BGC Partners.
Charity Day is held in commemoration of the 658 Cantor employees and 61 Eurobrokers employees lost in the 9/11 World Trade Center attacks.
To view the multimedia release go to:
http://www.multivu.com/players/English/7620751-cantor-bgc-partners-charity-day-2015/
With America’s nursing shortage and the soaring aging population, the nation’s largest senior living provider has launched a student loan reimbursement program with the goal of attracting more nurses to work in assisted living. Brookdale’s initiative comes as the U.S. Bureau of Labor Statistics projects the country’s nurse shortfall will exceed one million by 2022. People 65 and above are expected to comprise 16 percent of America’s population in 2020 and nearly 20 percent in 2030, compared to 13 percent in 2010, according to the U.S. Census Bureau. Brookdale operates more than 1,120 senior living communities in 47 states.
At Brookdale assisted living communities, nurses are hired as health and wellness directors, overseeing clinical services at a community including setting standards, leading health and wellness programming, and managing care associates. “This is a different kind of path than hospital nursing and it is a very important one,” said Kim Estes, senior vice president of clinical services for Brookdale. “Rather than providing hands-on care, these nurses shape the overall quality and content of care their community’s seniors receive on a daily basis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722156-brookdale-student-loan-program-nurses/
The Amos Family had a dream—to raise $1 million to help shelter dogs find forever homes. Now, with the help of pet industry leaders Wahl and GreaterGood.org, this dream is a reality. The Australian family of five has picked up and moved to the states, and for the next year their home will be an RV and a giant dog-shaped mobile dog washing vehicle. It’s called the Bathe to Save Tour, and its mission is to visit 150 cities in all 50 states, raise money and awareness, and wash more than 25,000 dogs to get them ready for adoption.
To view the multimedia release go to:
http://www.multivu.com/players/English/7978551-wahl-bathe-to-save-tour/
Taking center stage at the 2016 Chicago Auto Show are more than 20 vehicles that made their world debut during the Media Preview including the Kia Niro, Ram Power Wagon, Nissan Armada, Toyota Tacoma TRD Pro, Chevrolet Trax, Hyundai Santa Fe and Infiniti Q50 among others. More than a dozen concept cars are also on parade, including the Acura Precision, Buick Avista, Genesis Vision G, Kia Telluride and Nissan Murano Winter Warrior.
This year marks the 108th edition of the Chicago Auto Show. First staged in 1901, the Chicago Auto Show is the largest auto show in North America and has been held more times than any other auto exposition on the continent. The show runs from Feb. 13-21 and opens at 9 a.m. each day. There are nearly 1,000 different vehicles on display throughout the more than 1 million sq. ft. of McCormick Place.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660251-chicago-auto-show-2016/
Rowenta, maker of the revolutionary new air purifier the Intense Pure Air, is collaborating with renowned Environmental Toxicologist Dr. Noreen Khan-Mayberry (aka “The Tox Doc”), to help allergy sufferers better manage their symptoms. An estimated 50 million Americans are allergic to dust, dander, mold and mites, which can cause trouble breathing, excessive sneezing, eye irritation and coughing, amongst other ailments.
Seasonal allergies affect approximately 30% of U.S. residents and are worsening due to climate change, which is not only causing an increase in pollen levels, but also extending the length of pollen season. As such, allergy sufferers and people with asthma and other respiratory issues are at an even greater risk for heightened symptoms both indoors and outdoors.
To view the multimedia release go to:
http://www.multivu.com/players/English/7779051-rowenta-intense-allergen-air-purifier/
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
The National Climate Assessment: Climate Change Impacts in the United States concludes that warmer and drier conditions have already contributed to increasing wildfire events across the western United States, and future increases are projected in some regions. Already this year, there have been over 44,000 wildfires that have damaged or destroyed almost 8.5 million acres. Long periods of record high temperatures are associated with droughts that contribute to dry conditions and drive wildfires in some areas.
USDA Secretary Vilsack recently stated, “This year, we are experiencing yet another devastating wildfire season, particularly in the drought-ravaged West. Climate change, drought, fuel buildup, insects and disease are increasing the severity of unprecedented wildfire in America's forests and rangelands, which impacts the safety of people, homes and communities. Development close to forests has also increased the threat to property, with more than 46 million homes in the United States, or about 40 percent of our nation's housing, potentially at risk from wildfire.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7607931-fema-national-prepareathon/
With 830 women dying every day from preventable causes related to pregnancy and childbirth, and over 16,000 children under age five dying daily, Bayer and the White Ribbon Alliance today released critical policy recommendations and launched community programs to support the reduction and prevention of maternal, newborn and child mortality in two developing countries.1,2
Established through a three-year $1.3 million commitment from Bayer, these programs will expand work conducted by White Ribbon Alliance in Bangladesh and Zimbabwe to support the United Nations Secretary General’s Every Woman Every Child movement.
This announcement comes at the one-year anniversary of the Bayer/White Ribbon Alliance commitment in support of the Every Woman Every Child movement and will contribute to the success of the Sustainable Development Goals.
To view the multimedia release go to:
http://www.multivu.com/players/English/77126510-bayer-white-ribbon-alliance-self-care/
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Every spring, allergies take control of the lives of millions of Americans, affecting their work, their family time and even how well they sleep at night. Something else affects those millions of allergy sufferers, according to a new survey: big misconceptions about allergies that may keep people from getting needed relief.
To help put those misconceptions about allergies to rest, Sanofi is teaming up with science educator and television personality Adam Savage, along with allergist Dr. Neeta Ogden, to dispel them with credible information. The goal: help the 50 million allergy sufferers in America get the facts they need to understand and treat their allergies and take back control of their lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8255452-sanofi-allergy-misconceptions-facts-adam-savage/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
